Baldwin Insurance Group (BWIN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 revenue grew 11% year-over-year to $338.9 million, with organic revenue growth of 14% and adjusted EBITDA up 14% to $72.8 million, despite significant hurricane impacts in Florida.
Adjusted diluted EPS increased 14% to $0.33, while GAAP net loss narrowed 55% year-over-year to $14.5 million.
Year-to-date, revenue rose 13% to $1.1 billion, organic revenue grew 16%, and adjusted EBITDA increased 22% to $249.3 million.
Adjusted free cash flow for the nine months ended September 30, 2024, increased 31% to $99.2 million.
The company completed the sale of its Wholesale/Connected Risk business in early 2024, resulting in a $35.1 million pre-tax gain.
Financial highlights
Q3 2024 total revenue was $338.9 million, with organic revenue growth of 14% and commissions/fees of $335.2 million.
Adjusted EBITDA for Q3 was $72.8 million, with a margin of 21.5%, and adjusted net income was $38.5 million.
Adjusted free cash flow for Q3 was $27.8 million, up 15% year-over-year.
Net cash from operating activities for the nine months was $85.7 million; cash paid for interest YTD was $73.4 million.
Net leverage reduced to 4.2x, with a target of 3–4x by year-end.
Outlook and guidance
Q4 2024 revenue expected at $325–$335 million, with organic growth at the high end of the 10–15% range.
Q4 adjusted EBITDA expected at $61–$66 million; adjusted EPS at $0.25–$0.29.
Full-year 2024 adjusted EBITDA expected at $310–$315 million, margin accretion of ~200 bps, and adjusted free cash flow of $140–$150 million.
2025 outlook: organic growth at midpoint of 10–15% range, margin accretion of 25–100 bps, and improved free cash flow conversion.
Management highlights strong execution, operational effectiveness, and a focus on long-term growth and margin expansion.
Latest events from Baldwin Insurance Group
- Organic growth, tech investment, and successful M&A drive outperformance and future momentum.BWIN
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - 2025 saw robust growth and margin gains; 2026 targets acceleration with AI and $250M buyback.BWIN
Q4 202527 Feb 2026 - Q2 revenue up 14%, organic growth 19%, adjusted EBITDA up 22%, and free cash flow up 38%.BWIN
Q2 20242 Feb 2026 - Approaching a financial inflection point with accelerating growth, margin expansion, and free cash flow.BWIN
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Organic revenue up 19% in Q4, margins and free cash flow surged, outlook remains strong.BWIN
Q4 202429 Dec 2025 - Achieved rapid growth, strong margins, and is poised for higher free cash flow as earnouts end.BWIN
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202523 Dec 2025 - $1.026B merger forms the largest colleague-owned U.S. broker, targeting $60M synergies by 2028.BWIN
M&A Announcement3 Dec 2025 - Record growth, performance-based pay, and strong governance highlighted; all proposals recommended for approval.BWIN
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and auditor ratification.BWIN
Proxy Filing1 Dec 2025